EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation

Maria Jesus Valle-Pastor, Ignacio Cayuela, Jorge S Yebra, Lis Senach-Rasilla, Gloria Pastor-Fernández, Aurea Oliva, Javier Traba, Maria N Navarro

Journal of Allergy and Clinical Immunology · 2026-07 · 158 (1) · 164-181

DOI: 10.1016/j.jaci.2026.02.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-07. Verfasst von Maria Jesus Valle-Pastor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interactions with the Environment Program, Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior d…. Hauptthemen laut MEDLINE: Dasatinib, Interleukin-23, src-Family Kinases, Protein Kinase Inhibitors. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Centro de Biologia Molecular Severo Ochoa, Centro Nacional de Biotecnología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DasatinibInterleukin-23src-Family KinasesProtein Kinase InhibitorsDermatitisAnimalsSignal TransductionInterleukin-17Th17 CellsMiceHumansSkinFemaleDrug Evaluation, PreclinicalMechanistic Target of Rapamycin Complex 1InflammationImiquimod

Stichwörter der Autor:innen

IL-17IL-23Src kinasesdasatinibmTORpsoriasisγδ17 T cells

Substanzen

DasatinibInterleukin-23src-Family KinasesInterleukin-17Protein Kinase InhibitorsMechanistic Target of Rapamycin Complex 1Imiquimod

Autor:innen und Institutionen

  • Interactions with the Environment Program, Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
  • Physiological and Pathological Processes Program, Metabolic and Signaling Networks in Disease Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid, Spain; Department o…
  • Interactions with the Environment Program, Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid, Spain. Electronic address: mari…

Förderung

  • Centro de Biologia Molecular Severo Ochoa
  • Centro Nacional de Biotecnología

Zitieren

APA

Valle-Pastor, M. J., Cayuela, I., Yebra, J. S., Senach-Rasilla, L., Pastor-Fernández, G., Oliva, A., Traba, J., & Navarro, M. N. (2026). Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation. Journal of Allergy and Clinical Immunology, 158(1), 164-181. https://doi.org/10.1016/j.jaci.2026.02.036

Vancouver

Valle-Pastor MJ, Cayuela I, Yebra JS, Senach-Rasilla L, Pastor-Fernández G, Oliva A, et al. Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation. Journal of Allergy and Clinical Immunology. 2026;158(1):164-181. doi:10.1016/j.jaci.2026.02.036

BibTeX
@article{VallePastor2026,
  author = {Valle-Pastor, Maria Jesus and Cayuela, Ignacio and Yebra, Jorge S and Senach-Rasilla, Lis and Pastor-Fernández, Gloria and Oliva, Aurea and Traba, Javier and Navarro, Maria N},
  title = {Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {158},
  number = {1},
  pages = {164--181},
  doi = {10.1016/j.jaci.2026.02.036}
}
Kostenlos starten →